These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 20541444

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
    Schiene K, De Vry J, Tzschentke TM.
    J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties.
    Tzschentke TM, Christoph T, Kögel B, Schiene K, Hennies HH, Englberger W, Haurand M, Jahnel U, Cremers TI, Friderichs E, De Vry J.
    J Pharmacol Exp Ther; 2007 Oct; 323(1):265-76. PubMed ID: 17656655
    [Abstract] [Full Text] [Related]

  • 5. The influence of μ-opioid and noradrenaline reuptake inhibition in the modulation of pain responsive neurones in the central amygdala by tapentadol in rats with neuropathy.
    Gonçalves L, Friend LV, Dickenson AH.
    Eur J Pharmacol; 2015 Feb 15; 749():151-60. PubMed ID: 25576174
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice.
    Christoph T, Schröder W, Tallarida RJ, De Vry J, Tzschentke TM.
    J Pharmacol Exp Ther; 2013 Dec 15; 347(3):794-801. PubMed ID: 24051022
    [Abstract] [Full Text] [Related]

  • 8. Lack of synergistic interaction between the two mechanisms of action of tapentadol in gastrointestinal transit.
    Cowan A, Raffa RB, Tallarida CS, Tallarida RJ, Christoph T, Schröder W, Tzschentke TM.
    Eur J Pain; 2014 Sep 15; 18(8):1148-56. PubMed ID: 24574066
    [Abstract] [Full Text] [Related]

  • 9. Effect of tapentadol on neurons in the locus coeruleus.
    Torres-Sanchez S, Alba-Delgado C, Llorca-Torralba M, Mico JA, Berrocoso E.
    Neuropharmacology; 2013 Sep 15; 72():250-8. PubMed ID: 23664814
    [Abstract] [Full Text] [Related]

  • 10. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY, Zhao M, Yuan YK, Fan GX, Jia H, Tang JS.
    Neuroscience; 2006 Sep 15; 138(4):1319-27. PubMed ID: 16472929
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G, Baek CA, Erichsen HK, Nielsen AN, Nielsen EØ, Scheel-Kruger J, Weikop P, Peters D.
    Neuropharmacology; 2008 Feb 15; 54(2):331-43. PubMed ID: 18037451
    [Abstract] [Full Text] [Related]

  • 13. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M, Wang JY, Jia H, Tang JS.
    Brain Res; 2006 Mar 03; 1076(1):68-77. PubMed ID: 16476416
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dual μ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain.
    Mao XF, Ahsan MZ, Apryani E, Tang XQ, Zhao MJ, Li XY, Wang YX.
    Eur J Pharmacol; 2020 Jun 05; 876():173062. PubMed ID: 32173379
    [Abstract] [Full Text] [Related]

  • 20. [Tapentadol: with two mechanisms of action in one molecule effective against nociceptive and neuropathic pain. Preclinical overview].
    Tzschentke TM, Christoph T, Schröder W, Englberger W, De Vry J, Jahnel U, Kögel BY.
    Schmerz; 2011 Feb 05; 25(1):19-25. PubMed ID: 21258822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.